Pentair plc. Ordinary Share (PNR), Catalyst Pharmaceuticals (CPRX), California BanCorp (CALB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Pentair plc. Ordinary Share (PNR)
30.8% sales growth and 20.34% return on equity
Pentair plc provides various smart water solutions worldwide.
Pentair plc. Ordinary Share's sales growth this year is anticipated to be 17.5% and 5% for next year.
Year-on-year quarterly revenue growth grew by 22%, now sitting on 3.17B for the twelve trailing months.
Pentair plc. Ordinary Share's sales growth is a negative 0% for the current quarter and 30.8% for the next. The company's growth estimates for the current quarter and the next is 33.9% and 10%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.34%.
Volatility
Pentair plc. Ordinary Share's last day, last week, and last month's current volatility was 1.52%, 0.55%, and 1.22%, respectively.
Pentair plc. Ordinary Share's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.03% (day), 1.13% (last week), and 1.99% (last month), respectively.
Pentair plc. Ordinary Share's Stock Yearly Top and Bottom Value
Pentair plc. Ordinary Share's stock is valued at $66.79 at 23:22 EST, below its 52-week high of $70.76 and way higher than its 52-week low of $35.90.
Pentair plc. Ordinary Share's Moving Average
Pentair plc. Ordinary Share's worth is under its 50-day moving average of $67.69 and higher than its 200-day moving average of $60.77.2. Catalyst Pharmaceuticals (CPRX)
15.8% sales growth and 51.9% return on equity
Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States.
Catalyst Pharmaceuticals's sales growth this year is expected to be 10.2% and 14.4% for next year.
Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 120.14M for the twelve trailing months.
Catalyst Pharmaceuticals's sales growth is a negative 0% for the ongoing quarter and 15.8% for the next. The company's growth estimates for the current quarter and the next is a negative 0% and negative -73.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.9%.
Volatility
Catalyst Pharmaceuticals's last day, last week, and last month's current volatility was 0.70%, 1.68%, and 1.41%, respectively.
Catalyst Pharmaceuticals's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.11% (day), 4.00% (last week), and 3.62% (last month), respectively.
Catalyst Pharmaceuticals's Stock Yearly Top and Bottom Value
Catalyst Pharmaceuticals's stock is valued at $5.65 at 23:22 EST, under its 52-week high of $6.22 and way above its 52-week low of $2.88.
Catalyst Pharmaceuticals's Moving Average
Catalyst Pharmaceuticals's value is below its 50-day moving average of $5.66 and way above its 200-day moving average of $4.49.3. California BanCorp (CALB)
14.6% sales growth and 4.91% return on equity
California BanCorp operates as the bank holding company for California Bank of Commerce that provides commercial banking services to small to medium-sized businesses and professional firms in California.
California BanCorp's sales growth this year is expected to be 15.9% and 8.8% for next year.
Year-on-year quarterly revenue growth grew by 26.1%, now sitting on 46.93M for the twelve trailing months.
California BanCorp's sales growth is a negative 0% for the ongoing quarter and 14.6% for the next. The company's growth estimates for the present quarter and the next is 68.4% and 366.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.91%.
Volatility
California BanCorp's last day, last week, and last month's current volatility was 0.85%, 0.59%, and 1.22%, respectively.
California BanCorp's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.86% (day), 2.68% (last week), and 3.46% (last month), respectively.
California BanCorp's Stock Yearly Top and Bottom Value
California BanCorp's stock is valued at $18.43 at 23:22 EST, under its 52-week high of $19.88 and way higher than its 52-week low of $10.19.
California BanCorp's Moving Average
California BanCorp's value is higher than its 50-day moving average of $18.41 and higher than its 200-day moving average of $16.98.4. County Bancorp (ICBK)
11.9% sales growth and 8.81% return on equity
County Bancorp, Inc. operates as the bank holding company for Investors Community Bank that provides a range of consumer and commercial banking services to individuals, businesses, and industries primarily in northeastern and central Wisconsin.
County Bancorp's sales growth this year is anticipated to be 5.7% and 0.2% for next year.
Year-on-year quarterly revenue growth grew by 47.5%, now sitting on 52.65M for the twelve trailing months.
County Bancorp's sales growth for the next quarter is 11.9%. The company's growth estimates for the present quarter and the next is 60% and negative -1.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.81%.
Volatility
County Bancorp's last day, last week, and last month's current volatility was 0.40%, 1.42%, and 1.34%, respectively.
County Bancorp's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.58% (day), 3.24% (last week), and 2.57% (last month), respectively.
County Bancorp's Stock Yearly Top and Bottom Value
County Bancorp's stock is valued at $34.46 at 23:22 EST, under its 52-week high of $35.82 and way higher than its 52-week low of $17.04.